Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance

April 15, 2026

As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9...

Via MarketMinute

Topics Economy

Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A

April 15, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...

Via MarketMinute

Topics Economy

Demystifying Inari Medical: Insights From 6 Analyst Reviews ↗

December 17, 2024

Via Benzinga

Key Takeaways From Inari Medical Analyst Ratings ↗

October 29, 2024

Via Benzinga

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The...

Via MarketMinute

Topics Artificial Intelligence

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

January 14, 2026

As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial...

Via MarketMinute

Topics Artificial Intelligence

If You Could Only Hold 3 Investments for Life, Consider These

March 10, 2025

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Via MarketBeat

Topics ETFs Economy Retirement

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, TGI, AVAV, NARI on Behalf of Shareholders

February 05, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, NARI, VTS, QTRX on Behalf of Shareholders

January 24, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NARI, QTRX, CTV on Behalf of Shareholders

January 23, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HEES, NARI, SSTK on Behalf of Shareholders

January 14, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: H&E Equipment Services, Inc. (Nasdaq - HEES), Inari Medical, Inc. (Nasdaq - NARI), Paycor HCM, Inc. (Nasdaq - PYCR), Shutterstock, Inc. (NYSE - SSTK)

January 14, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?

Via Benzinga

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders

January 11, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NEUE, VCSA, SSTK, NARI on Behalf of Shareholders

January 09, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

January 08, 2025

From Halper Sadeh LLC

Via GlobeNewswire

INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI

January 07, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

January 07, 2025

Via Benzinga

Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position ↗

January 07, 2025

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.

Via Benzinga

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket ↗

January 07, 2025

Via Benzinga

NARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to Shareholders

January 06, 2025

From Halper Sadeh LLC

Via Business Wire

Inari Medical Catapults 30% On Rumored Stryker Takeover ↗

January 06, 2025

Inari is best-known for its series of catheter-like devices that remove blood clots.

Via Investor's Business Daily

Inari Medical to Present at the J.P. Morgan Healthcare Conference

January 03, 2025

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical Stock Gets RS Rating Upgrade ↗

December 11, 2024

On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

Via Investor's Business Daily

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

December 02, 2024

Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical Announces Joint Venture in Greater China

December 02, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical to Participate in the Jefferies London Healthcare Conference

November 06, 2024

From Inari Medical, Inc.

Via GlobeNewswire

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

October 29, 2024

Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization

From Inari Medical, Inc.

Via GlobeNewswire

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗

October 29, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.